FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Overview Fund Activity
Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

23 hedge funds and large institutions have $3.96M invested in F-star Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$84K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$693K
3
Northern Trust
3
Northern Trust
Illinois
$67K
4
UBS Group
4
UBS Group
Switzerland
$3K
5
Osaic Holdings
5
Osaic Holdings
Arizona
$2K

Top Sellers

1
ED
1
Exane Derivatives
France
$0
2
ECM
2
ExodusPoint Capital Management
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$569K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$8K
Name Market Value Shares Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
– – -2 Closed
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
– – – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
29
Wells Fargo
California
$0 97 +19 +24%
1
2